Erratum to: The DNA methyltransferase inhibitor zebularine exerts antitumor effects and reveals BATF2 as a poor prognostic marker for childhood medulloblastoma
Invest New Drugs. 2017 Feb;35(1):124.
doi: 10.1007/s10637-016-0412-1.
1 Department of Genetics, Ribeirão Preto Medical School, University of São Paulo (USP), Avenida Bandeirantes 3900, 14048-900, Ribeirão Preto, SP, Brazil. augustofaria@usp.br.
2 Departamento de Genética, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Avenida Bandeirantes 3900, 14048-900, Ribeirão Preto, SP, Brazil. augustofaria@usp.br.
3 Department of Pediatrics - Ribeirão Preto Medical School, University of São Paulo (USP), São Paulo, Brazil.
4 Department of Genetics, Ribeirão Preto Medical School, University of São Paulo (USP), Avenida Bandeirantes 3900, 14048-900, Ribeirão Preto, SP, Brazil.
5 Department of Biochemistry, Chemistry Institute, USP, São Paulo, Brazil.
6 Department of Surgery and Anatomy, Ribeirão Preto Medical School, USP, São Paulo, Brazil.
7 Department of Pathology, Ribeirão Preto Medical School, USP, São Paulo, Brazil.
8 Centro Infantil Boldrini & FCM/Unicamp, Campinas, Brazil.